Trimeris Inc. / Computershare Shareowner Services LLC / AnorMED Inc. / PricewaterhouseCoopers LLP / Seattle Genetics Inc. / Alder BioPharmaceuticals Inc. / Takeda Oncology Company / Genomic Health Inc. / Neurogen Corporation / Millennium Pharmaceuticals Inc. / Biogen Idec / Mirna Therapeutics Inc. / Conjuchem Inc. / Tisch Family / ArQule Inc. / Baker Brothers Investments / Ardea BioScience Inc. / Ultragenyx Pharmaceutical Inc. / Syros Pharmaceuticals Inc. / Synageva Inc. / D. / /
Event
Employment Change / General or Shareholder Meeting / Business Partnership / /
Facility
George Washington University / Stanford University / Princeton University / Massachusetts General Hospital / University of Pennsylvania Medical School / building Seattle Genetics / National Cancer Institute / University of Maryland / Bristol-Myers Squibb Pharmaceutical Research Institute / /
IndustryTerm
registered public accounting / Delaware law / pharmaceutical industry / bank / biotechnology investing partnership / biotechnology / traded biotechnology / Internet availability / privatelyheld biotechnology / biotechnology industry / publicly-traded biotechnology / /
Organization
University of Maryland / Compensation Committee / Audit Committee / Princeton University / U.S. Securities and Exchange Commission / George Washington University / Bristol-Myers Squibb Pharmaceutical Research Institute / Securities and Exchange Commission / Harvard Medical School / National Cancer Institute / Nominating and Corporate Governance Committee / Personalized Medicine Coalition / Damon Runyan Foundation / the University of Pennsylvania / Massachusetts General Hospital / Current / University of Pennsylvania Medical School / Stanford University / /
Person
Julian Baker / John A. Orwin / Marc E. Lippman / David W. Gryska / Nancy A. Simonian / Daniel G. Welch / Srinivas Akkaraju / NOMINEE PROFILES / Clay B. Siegall / Jean I. Liu / John P. McLaughlin / Felix Baker / / /
Position
Corporate Secretary / President / broker / Chief Executive Officer / continuing director / Vice President of Clinical Research / Chief Medical Officer and Senior Vice President of Clinical / Director June / Director Nominee Age Company Positions/Offices / Managing Partner / Chief Scientific Officer / lead independent director / Chief Executive Officer and Chairman of the Board / President and Chief Executive Officer / representative / Principal Scientist / board member / Director Director Director Director Director Director / fund-manager / Inspector / Age Company Positions/Offices Director / Class II director / Board Lead Independent Director Director / executive officers / nominee and continuing director / senior executive / professor of neurology / Governor / Chairman / director nominations / Director discussions and company strategy / director / director nominees / Senior Vice President of Clinical / Medical and Regulatory Affairs / Director July / Board chairman / ABSTENTIONS AND BROKER / executive / Ph. President and Chief Executive Officer / co-founder / /
® April 6, 2015 Dear Seattle Genetics Stockholders: On behalf of Seattle Genetics, Inc., I cordially invite you to attend our 2015 Annual Meeting of Stockholders to be held on Friday, May 15, 2015, at 11:00 a.m., local